RichardAndrewMurphyMD

Assistant Professor, Medicine, Albert Einstein College of Medicine of Yeshiva Uni

Dr. Murphy is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
1520 San Pablo St
Suite 1000
Los Angeles, CA 90033
Phone+1 323-442-5100

Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Infectious Disease, 2005 - 2009
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2001 - 2005
Duke University School of MedicineClass of 2001

PubMed

5 citations
Detection of HIV Virologic Failure and Switch to Second-Line Therapy: A Systematic Review and Meta-analysis of Data From Sub-Saharan Africa.
Kerlly J Bernabé, Mark Siedner, Alexander C Tsai, Vincent C Marconi, Richard A Murphy
Open Forum Infectious Diseases. 2022-05-01
7 citations
Double-dose lopinavir-ritonavir in combination with rifampicin-based anti-tuberculosis treatment in South Africa.
Henry Sunpath, Winternheimer P, Cohen S, Tennant I, N. Chelin
The International Journal of Tuberculosis and Lung Disease. 2014-06-01
38 citations
Second-Line Antiretroviral Therapy in Sub-Saharan Africa: It Is Time to Mind the Gaps
Richard A. Murphy, Richard Court, Gary Maartens, Henry Sunpath
AIDS Research and Human Retroviruses. 2017-12-01

FDA Adviser Recommends Full Approval of Pfizer’s Covid Drug PaxlovidMarch 17th, 2023
Advisors to the US Food and Drug Administration (FDA) Recommend Full Approval of Pfizer’s Covid Drug PaxlovidMarch 17th, 2023
FDA Advisors Recommend Full Approval of Pfizer Covid Treatment Paxlovid for Adults 50 and over and Other High-Risk PeopleMarch 16th, 2023
Join now to see all